|
Market Closed -
Other stock markets
|
After hours 01:29:59 am | |||
| 0.8900 EUR | +0.23% |
|
0.8910 | +0.11% |
| 10/06 | AB Science presents new data on Masitinib |  |
| 18/05 | AB Science S.A. announced that it has received $2.989368 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.83Cr | - | - | - | - | |
| 6.78TCr | |||||
| 838.95Cr | |||||
| 792.17Cr | |||||
| 452.92Cr | |||||
| 372.33Cr |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
